Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free IMMX Stock Alerts

Immix Biopharma (IMMX) Earnings Date, Estimates & Call Transcripts

Immix Biopharma logo
$8.84 +0.06 (+0.68%)
Closing price 05/26/2026 04:00 PM Eastern
Extended Trading
$8.98 +0.14 (+1.53%)
As of 08:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Immix Biopharma Earnings Summary

Immix Biopharma released Q1 2026 earnings on May 7, 2026, reporting an EPS of -$0.18, which beat the consensus estimate of -$0.19 by $0.01. With a trailing EPS of -$0.92, Immix Biopharma's earnings are expected to grow next year, from ($0.78) to ($0.73) per share.

Upcoming Q2
Earnings Date
Jun. 3After Market ClosesEstimated
Consensus EPS
(May. 7)
-$0.19
Actual EPS
(May. 7)
-$0.18 Beat By $0.01

Q1 2026 Earnings Resources

IMMX Upcoming Earnings

Immix Biopharma's Q1 2026 earnings is estimated for Wednesday, June 3, 2026, based on past reporting schedules

Powered by Quartr
Get Immix Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immix Biopharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IMMX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Immix Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.14-$0.14-$0.14
Q2 20261-$0.15-$0.15-$0.15
Q3 20261-$0.14-$0.14-$0.14
Q4 20261-$0.15-$0.15-$0.15

Immix Biopharma Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
6/3/2026
(Estimated)		--------
5/7/2026Q1 2026-$0.1909-$0.18+$0.0109-$0.18--
3/25/2026Q4 2025-$0.16-$0.28 -$0.12-$0.28--
11/7/2025Q3 2025-$0.19-$0.24 -$0.05-$0.24--
8/8/2025Q1 2025-$0.21-$0.22 -$0.01-$0.22--
3/24/2025Q4 2024-$0.25-$0.16+$0.09-$0.16--
11/12/2024--$0.16-$0.24 -$0.08-$0.24--
8/12/2024--$0.21-$0.15+$0.06-$0.15--

Data powered by Fiscal.ai.

Immix Biopharma Earnings - Frequently Asked Questions

Immix Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 3rd, 2026 based off last year's report dates. Learn more on IMMX's earnings history.

In the previous quarter, Immix Biopharma (NASDAQ:IMMX) reported ($0.18) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.01. Learn more on analysts' earnings estimate vs. IMMX's actual earnings.

Immix Biopharma (NASDAQ:IMMX) has a recorded net income of -$29.44 million. IMMX has generated -$0.92 earnings per share over the last four quarters.

Immix Biopharma's earnings are expected to grow from ($0.78) per share to ($0.73) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:IMMX) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel